0QB7.LSE Borregaard ASA
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- 2.72%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2023.
Is 0QB7.LSE undervalued?
Graham numberThe Graham number of Borregaard ASA cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Borregaard ASA fundamental analysis
No fundamental analysis for Borregaard ASA yet.
Borregaard ASA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Borregaard ASA
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance compani…
Full company profileBorregaard ASA financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Borregaard ASA annual financial statements (NOK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 4.62B | 4.79B | 5.06B | 5.33B | 5.81B | - | - |
| Gross Profit | 2.55B | 2.51B | 2.73B | 2.87B | - | - | - |
| Operating Income | 736M | 576M | 558M | 568M | 952M | - | - |
| Net Income | 566M | 476M | 417M | 436M | 692M | - | - |
| Balance Sheet | |||||||
| Total Assets | 5.33B | 5.95B | 6.74B | 7.00B | 7.17B | - | - |
| Total Liabilities | 2.44B | 2.83B | 3.44B | 3.34B | 2.94B | - | - |
| Shareholders' Equity | 2.89B | 3.12B | 3.31B | 3.67B | 4.22B | - | - |
| Cash & Short-term Investments | 180M | 86.0M | 147M | 207M | 124M | - | - |
| Total Debt | 743M | 1.12B | 1.42B | 1.38B | 1.32B | - | - |
| Cash Flow | |||||||
| Operating Cash Flow | 780M | 558M | 697M | 886M | 1.43B | 735M | - |
| Capital Expenditure | 968M | 760M | 570M | 494M | 537M | 459M | 0.00 |
| Ratios | |||||||
| ROE | 19.6% | 15.2% | 12.6% | 11.9% | 16.4% | - | - |
| ROA | 10.6% | 8.0% | 6.2% | 6.2% | 9.7% | - | - |
| Net Profit Margin | 12.3% | 9.9% | 8.2% | 8.2% | 11.9% | - | - |
| Debt to Equity | 0.26x | 0.36x | 0.43x | 0.38x | 0.31x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Borregaard ASA dividends
Borregaard ASA has not paid dividends in the last 8 fiscal years.
Who owns Borregaard ASA
- Insiders 7.16%
- Institutions 58.04%
- Public & others 34.79%
- Free float 99.1M
Borregaard ASA company profile
- Company name
- Borregaard ASA
- Ticker
- 0QB7.LSE
- Exchange
- London Exchange
- Sector
- Basic Materials
- Industry
- Commercial Services & Supplies
- Employees
- 1,193
- Fiscal year end
- December
- Address
- PO Box 162, Sarpsborg, Norway, 1701
- Phone
- 47 69 11 80 00
- Website
- borregaard.com
About Borregaard ASA
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry. Its BioMaterials segment develops, produces, and sells speciality cellulose used as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products, as well as cellulose fibrils for industrial applications. The Fine Chemicals segment supplies fine chemical intermediates for contrast agents and advanced bioethanol. The company was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
Borregaard ASA management
10- Mr. Tom Erik Foss-JacobsenChief Executive Officer · born 1969
- Mr. Per Bjarne LyngstadChief Financial Officer · born 1961
- Mr. Dag Arthur AasbøSenior Vice President of Public Affairs & Sustainability · born 1961
- Ms. Kari StrandeSenior VP of Human Resources · born 1962
- Mr. Gisle Løhre JohansenExecutive Vice President of Speciality Cellulose & Fine Chemicals · born 1959
- Mr. Ole Gunnar JakobsenExecutive VP of Manufacturing & Technology · born 1969
- Ms. Kristin MisundSenior Vice President of R&D and Business Development · born 1965
- Ms. Liv LongvaSenior Vice President of Procurement & Strategic Sourcing · born 1969
- Mr. Knut-Harald BakkeExecutive Vice President of BioSolutions
- Ms. Guro Elise FredheimChief Technology Officer